Article info
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature
- Correspondence to Dr Hafez Mohammad Ammar Abdullah, ammar.abdullah{at}usd.edu
Citation
Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature
Publication history
- Accepted August 3, 2019
- First published August 26, 2019.
Online issue publication
January 25, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.